TriSalus Life Sciences (TLSI) Research & Development (2022 - 2026)

TriSalus Life Sciences (TLSI) has 5 years of Research & Development data on file, last reported at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 6.45% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $14.9 million (changed 0.13% YoY), and the FY2025 full-year result was $15.0 million, down 15.39% from the prior year.
• Research & Development for Q1 2026 stood at $3.2 million, up from $2.6 million in the prior quarter.
• Across five years, Research & Development topped out at $9.5 million in Q3 2023 and bottomed at $2.6 million in Q4 2025.
• The 5-year median for Research & Development is $4.8 million (2022), against an average of $5.1 million.
• The widest annual swing landed in 2023, when Research & Development jumped 97.71%; it then sank 61.91% in 2024.
• A 5-year view of Research & Development shows it stood at $6.3 million in 2022, then rose by 23.97% to $7.8 million in 2023, then tumbled by 61.91% to $3.0 million in 2024, then fell by 13.15% to $2.6 million in 2025, then climbed by 25.14% to $3.2 million in 2026.
• The last three Research & Development figures came in at $3.2 million (Q1 2026), $2.6 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.

Peer Comparison